Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05264857 · ClinicalTrials.gov registry record · NA

Decision Aid and Thyroid Nodules Management

A NA study of Thyroid Nodule, sponsored by Stony Brook University.

Recruiting
Registry status
NA
Development phase
134
Enrollment target
1
Study location

NCT05264857 is a NA study of Thyroid Nodule that is actively recruiting participants, run by Stony Brook University. The registered enrollment target is 134 participants, above the 57-participant average among 5 other Thyroid Nodule trials with a reported enrollment target (135% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05264857, a NA study of Thyroid Nodule, is actively recruiting participants, sponsored by Stony Brook University.

RECRUITING
Registry status
NA
Development phase
134 participants
Enrollment target
1
Study location

Study Summary

Patients with small favorable malignant or indeterminate thyroid nodules will receive information about management of thyroid nodules. Participants will be asked to complete brief surveys at the time of enrollment, shortly after the consultation appointment with the surgeon, and a few months after either the consultation or the surgery, to assess their satisfaction with their decision and decision making process. All participants will receive routine care and counseling by their endocrinologist and surgeon.

Conditions Studied

Interventions

  • BEHAVIORAL Thyroid Nodule Management Education

Study Locations (1)

New York

  • Stony Brook University Cancer Center - Stony Brook

Trial Details

FieldValue
Enrollment Target 134 participants
Start Date 2022-02-08
Est. Completion 2027-09-30
Phase NA

Sponsor

Stony Brook University

127 total trials

What the Registry Record Tells You About NCT05264857

The ClinicalTrials.gov registry entry for NCT05264857 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 57-participant average among 5 other Thyroid Nodule trials with a reported enrollment target (135% higher). The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Thyroid Nodule appearing as the primary indexed condition, and to 1 intervention - of which Thyroid Nodule Management Education is the first listed.

NCT05264857 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05264857 about?

NCT05264857 is a clinical study titled "Decision Aid and Thyroid Nodules Management". Patients with small favorable malignant or indeterminate thyroid nodules will receive information about management of thyroid nodules. Participants will be asked to complete brief surveys at the time of enrollment, shortly after the consultation appointment with the surgeon, and a few months after e...

What is the current status of trial NCT05264857?

This trial is currently recruiting. It is a NA study. The enrollment target is 134 participants. The study started on 2022-02-08. Estimated completion is 2027-09-30.

What conditions does trial NCT05264857 study?

This clinical trial studies the following conditions: Thyroid Nodule.

What interventions are being tested in trial NCT05264857?

The interventions under investigation include: Thyroid Nodule Management Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT05264857?

This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05264857 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Thyroid Nodule

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.